JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB137560

Anti-SFRP2 antibody - C-terminal

Be the first to review this product! Submit a review

|

(17 Publications)

Rabbit Polyclonal SFRP2 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 17 publications. Immunogen corresponding to Synthetic Peptide within Human SFRP2 aa 200 to C-terminus.

View Alternative Names

FRP2, SARP1, FKSG12, UNQ361/PRO697, SFRP2, Secreted frizzled-related protein 2, FRP-2, sFRP-2, Secreted apoptosis-related protein 1, SARP-1

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-SFRP2 antibody - C-terminal (AB137560)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-SFRP2 antibody - C-terminal (AB137560)

Immunofluorescent analysis of paraformaldehyde-fixed A431 cells labelling SFRP2 with ab137560 at 1/200 dilution. Lower image is merged with DNA probe.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SFRP2 antibody - C-terminal (AB137560)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SFRP2 antibody - C-terminal (AB137560)

Immunohistochemical analysis of paraffin-embedded MCF7 xenograft labelling SFRP2 with ab137560 at 1/500 dilution.

Western blot - Anti-SFRP2 antibody - C-terminal (AB137560)
  • WB

Supplier Data

Western blot - Anti-SFRP2 antibody - C-terminal (AB137560)

Samples were separated by 12% SDS-PAGE. Corresponding RNA expression data for the same cell lines are based on Human Protein Atlas program.

All lanes:

Western blot - Anti-SFRP2 antibody - C-terminal (ab137560) at 1/500 dilution

Lane 1:

NT2D1 whole cell extracts at 30 µg

Lane 2:

HeLa whole cell extracts at 30 µg

Secondary

All lanes:

HRP-conjugated anti-rabbit IgG antibody

Predicted band size: 33 kDa

false

Western blot - Anti-SFRP2 antibody - C-terminal (AB137560)
  • WB

CiteAb

Western blot - Anti-SFRP2 antibody - C-terminal (AB137560)

SFRP2 western blot using anti-SFRP2 antibody - C-terminal ab137560. Publication image and figure legend from Cai, J., Fang, L., et al., 2017, Nat Commun, PubMed 28627514.

ab137560 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab137560 please see the product overview.

miR-128-3p targets Axin1, SFRP2, WIF1, SMURF2 and PP1c in NSCLC cells.(a) Targetscan tool showing schematic representation of putative binding sites for miR-128-3p in 3'-UTRs of Axin1, SFRP2, WIF1, SMURFS and PP1c. (b) WB analysis of the protein levels of Axin1, SFRP2, WIF1, SMURF2 and PP1c in the indicated cells. (c) By immunoprecipitation against Ago1, RIP analysis reveals the interaction of miR-128-3p with the 3'-UTRs of Axin1, SFRP2, WIF1, SMURF2 or PP1c mRNA to form miRNP complexes. IgG immunoprecipitation, as well as the interaction of miR-128-3p with GAPDH and 5s rRNA, were used as negative controls. (d) Luciferase assay of pGL3-Axin1-3'-UTR, pGL3-SFRP2-3'-UTR, pGL3-SMURF2-3'-UTR, pGL3-PP1c-3'-UTR or pGL3-WIF1-3'-UTR reporters in the indicated cells, co-transfected with increasing amounts (20 and 50 nM) of the indicated oligonucleotides. The sequence of the miR-128-3p mutant is shown. (e) Effects of restoredexpression of Axin1, SFRP2, WIF1, SMURFS and PP1c in miR-128-3p-overexpressing cells on luciferase activities of the TOP/FOP reporter and TGF-β reporter. (f) Effects of restored expression of miR-128-3p target genes on cell migration and self-renewal measured by Transwell migration assay and sphere formation assay, respectively, in the indicated NSCLC cells. Error bars represent mean±s.d. derived from three independent experiments. A two-tailed Student's t-test was used for statistical analysis (*p<0.05, **p<0.01).

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, IHC-P

applications

Immunogen

Synthetic Peptide within Human SFRP2 aa 200 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q96HF1

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/1000", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p>Perform heat mediated antigen retrieval before commencing with IHC staining protocolusing 10mM citrate buffer (pH6.0) or Tris-EDTA buffer (pH8.0).</p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Zebrafish": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 Preservative: 0.025% Proclin 300 Constituents: PBS, 20% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SFRP2 also known as Secreted Frizzled-Related Protein 2 is a protein that primarily functions as a modulator of the Wnt signaling pathway. It is a secreted glycoprotein with an approximate mass of 35 kDa. SFRP2 contains a cysteine-rich domain that is homologous to the Wnt-binding site of Frizzled proteins. This protein is widely expressed in various tissues including the heart lung and kidneys. Its primary role involves regulating the activity of Wnt proteins by direct binding which impacts cell signaling processes.
Biological function summary

SFRP2 plays a significant role in the regulation of cellular proliferation migration and differentiation. It often functions as a part of extracellular signaling complexes influencing tissue development and repair. SFRP2 has been implicated in controlling the balance between cell growth and apoptosis particularly in stem cell environments and developing organ systems. Its activity impacts embryonic development contributing to the formation and patterning of tissues by modulating the Wnt signaling cascade.

Pathways

Scientists have extensively studied SFRP2 in the context of the Wnt signaling and angiogenesis pathways. In the Wnt signaling pathway SFRP2 intervenes by sequestering Wnt ligands and preventing them from activating Frizzled receptors thereby modulating downstream β-catenin activities. The protein shows interaction with other Wnt pathway components like DKK1 which also modulates Wnt signaling. In the angiogenesis pathway SFRP2's involvement affects vascular formation and stability linking it to proteins such as VEGF a critical regulator of blood vessel growth.

Researchers have linked SFRP2 to cancer and cardiac conditions. In cancer abnormal SFRP2 expression has been associated with tumor progression and metastasis often through its interaction with other Wnt pathway proteins like β-catenin and DKK1 altering cell survival and division. In cardiac disorders altered levels of SFRP2 impact heart remodeling and fibrosis connecting to proteins such as TGF-β involved in fibrotic processes. Scientists continue to investigate SFRP2's role in these conditions to develop targeted therapeutic strategies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Soluble frizzled-related proteins (sFRPS) function as modulators of Wnt signaling through direct interaction with Wnts. They have a role in regulating cell growth and differentiation in specific cell types. SFRP2 may be important for eye retinal development and for myogenesis.
See full target information SFRP2

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:2532 PubMed40087279

2025

FoxO3 controls cardiomyocyte proliferation and heart regeneration by regulating Sfrp2 expression in postnatal mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jing-Bo Xia,Kun Liu,Xiao-Lin Lin,Hong-Ji Li,Jin-Hua Lin,Li Li,Chi-Qian Liang,Yan Cao,Na Wen,Zhao-Fu Liao,Hui Zhao,Kyu-Sang Park,Guo-Hua Song,Ze-Bing Ye,Dong-Qing Cai,Zhen-Yu Ju,Xu-Feng Qi

Communications biology 8:284 PubMed39987372

2025

Emergence of inflammatory fibroblasts with aging in Hermansky-Pudlak syndrome associated pulmonary fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Brandon J H Banaschewski,Sylvia N Michki,Sneha Sitaraman,Ruby Pan,Joanna Y Wang,Dominique Stewart,Mary Kate Goldy,Susan M Lin,Edward Cantu,Jeremy B Katzen,Maria C Basil,Amir M Emtiazjoo,Jamie L Todd,Jason J Gokey,Jonathan A Kropski,David B Frank,Jarod A Zepp,Lisa R Young

Molecular medicine reports 29: PubMed38426532

2024

SFRP2 suppresses trophoblast cell migration by inhibiting the Wnt/β‑catenin pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ruihong Lan,Yihong Yu,Jie Song,Mengdi Xue,Humin Gong

Cancer biomarkers : section A of Disease markers 38:287-300 PubMed37955079

2023

Secreted frizzled related-protein 2 is prognostic for human pancreatic cancer patient survival and is associated with fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Julie B Siegel,Patrick Nasarre,Lillian Hsu,Rupak Mukherjee,Meghan Gormley,Bailey Richardson,Imran Khan,Jordan E Morningstar,Eleanor Hilliard,John P O'Bryan,Kristi L Helke,Laura Spruill,Nathan G Dolloff,Nancy Klauber-DeMore

Nature ecology & evolution 7:2143-2159 PubMed37813945

2023

A multifunctional Wnt regulator underlies the evolution of rodent stripe patterns.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew R Johnson,Sha Li,Christian F Guerrero-Juarez,Pearson Miller,Benjamin J Brack,Sarah A Mereby,Jorge A Moreno,Charles Y Feigin,Jenna Gaska,Jaime A Rivera-Perez,Qing Nie,Alexander Ploss,Stanislav Y Shvartsman,Ricardo Mallarino

Cells 11: PubMed36552843

2022

SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Elif Akova Ölken,Attila Aszodi,Hanna Taipaleenmäki,Hiroaki Saito,Veronika Schönitzer,Michael Chaloupka,Maria Apfelbeck,Wolfgang Böcker,Maximilian Michael Saller

Cancer discovery 12:2906-2929 PubMed36305747

2022

Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Mo,Shoufu Duan,Xu Zhang,Xu Hua,Hui Zhou,Hong-Jian Wei,Jun Watanabe,Nicholas McQuillan,Zhenyi Su,Wei Gu,Cheng-Chia Wu,Christopher R Vakoc,Rintaro Hashizume,Kenneth Chang,Zhiguo Zhang

PloS one 16:e0260864 PubMed34852024

2021

Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Quansheng Wu,Xiaofeng Yin,Wenbo Zhao,Wenli Xu,Laizhao Chen

Developmental cell 56:95-110.e10 PubMed33207226

2020

Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.

Applications

Unspecified application

Species

Unspecified reactive species

Hiroaki Kasashima,Angeles Duran,Anxo Martinez-Ordoñez,Yuki Nakanishi,Hiroto Kinoshita,Juan F Linares,Miguel Reina-Campos,Yotaro Kudo,Antoine L'Hermitte,Masakazu Yashiro,Masaichi Ohira,Fei Bao,Daniele V F Tauriello,Eduard Batlle,Maria T Diaz-Meco,Jorge Moscat

Clinical cancer research : an official journal of the American Association for Cancer Research 26:5709-5719 PubMed33097493

2020

sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Mitchell E Fane,Brett L Ecker,Amanpreet Kaur,Gloria E Marino,Gretchen M Alicea,Stephen M Douglass,Yash Chhabra,Marie R Webster,Andrea Marshall,Richard Colling,Olivia Espinosa,Nicholas Coupe,Neera Maroo,Leticia Campo,Mark R Middleton,Pippa Corrie,Xiaowei Xu,Giorgos C Karakousis,Ashani T Weeraratna
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com